Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer
Status:
Withdrawn
Trial end date:
2013-12-02
Target enrollment:
Participant gender:
Summary
This clinical trial studies tivozanib before surgery in treating patients with localized
kidney cancer. Tivozanib may stop the growth of tumor cells by blocking some of the growth
factors needed for cell growth.
Phase:
N/A
Details
Lead Sponsor:
Roswell Park Cancer Institute
Collaborators:
AVEO Pharmaceuticals, Inc. National Cancer Institute (NCI)